Author: openjargon

BHP Group Ltd (ASX: BHP) is already one of the biggest mining shares in the world.

But what could the business look like in five years?

Its commodity mix is changing, major growth projects are progressing, and some of its biggest markets could look quite different by 2031.

So, is BHP the ASX mining share I would want to own for that journey?

Copper could become even more important

The biggest reason I am positive about BHP’s next five years is copper.

It has already become a much larger part of the business. In FY26, copper contributed more than half of BHP’s underlying EBITDA for the first time, while the company produced around 2 million tonnes for the second consecutive year.

I think the longer-term opportunity is even more compelling. Electrification, renewable energy, data centres, and AI infrastructure all require enormous amounts of copper. BHP expects global demand to rise from around 34 million tonnes a year today to more than 50 million tonnes by 2050.

The company is positioning itself accordingly. It has growth options across Chile, South Australia, Argentina, and the United States, with management believing its copper pipeline could lift attributable production by around 40% by FY35.

Not all of that will arrive within five years, but I think the direction is clear. BHP is becoming increasingly geared towards a commodity that could face strong structural demand.

Iron ore still has an important job

I would not overlook iron ore simply because copper is getting more attention.

BHP’s Western Australian iron ore operations remain a major source of cash, and FY26 delivered record production and shipments. The business also retains its position as one of the lowest-cost major producers globally.

That is important because iron ore can help fund the next phase of growth.

China’s property sector remains a risk, but BHP still expects Chinese steel production to stay around 1 billion tonnes annually through the remainder of this decade, while India is becoming increasingly important as infrastructure and industrial investment expand.

In my opinion, iron ore does not need to be the growth engine. It can remain the dependable cash generator behind the rest of the portfolio.

A new commodity joins the mix

The next five years should also see potash become meaningful. BHP’s Jansen project in Canada is on track for first production in mid-2027. Stage 1 is already well advanced, while Stage 2 is designed to eventually help take the combined output to around 8.5 million tonnes a year.

Potash gives BHP exposure to agriculture and food production, which brings a different demand driver from metals such as copper and iron ore.

I think that diversification could become increasingly valuable as Jansen ramps up.

What could go wrong?

BHP is still a commodity producer, so prices will have a major influence on returns.

A sharp fall in copper or iron ore prices could outweigh operational progress, while large projects such as Jansen and future copper developments bring execution and cost risks.

I would also expect the dividend to move around with the cycle. BHP can offer a good dividend yield at times, but I would not buy it expecting a perfectly smooth income stream.

Foolish takeaway

For me, BHP would be the ASX mining share I would most want to own over the next five years.

Iron ore should continue providing substantial cash flow, copper is becoming a much bigger part of the growth story, and potash adds another long-term opportunity.

There will be commodity cycles along the way, but I think BHP’s portfolio is moving in the right direction for the world investors are likely to face in 2031.

The post Is BHP the best ASX mining share to buy for the next 5 years? appeared first on The Motley Fool Australia.

More reading

• How much passive income can I earn from a $950,000 superannuation balance?
• Buy, hold, sell: Goodman, Wesfarmers, BHP shares
• Woodside Energy vs Rio Tinto: Which ASX 200 stock is better value?
• PLS vs BHP: Which ASX 200 mining stock looks better today?
• How much superannuation do I need to earn $56,000 per year in passive income?

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Life360 vs Droneshield shares: Which ASX tech stock stands out?

Picking between two innovative tech shares on the ASX can feel like comparing apples to oranges, but if you’re weighing up Life360 Inc (ASX: 360) versus Droneshield Ltd (ASX: DRO), you’re not alone. Both operate at the cutting edge of technology—Life360 in global safety apps for families and friends, Droneshield on the frontline of drone detection. So, which one shines brighter as a buy right now? Here’s how the numbers and business models stack up.

The case for Life360

Life360 is a US-based software company best known for its popular family safety and location-sharing app, available in multiple languages across the world. It boasts over 104 million monthly active users, connecting families and friends to share whereabouts, communicate, and get help with roadside emergencies, theft identification, and more. The company has also pushed into the advertising market with its acquisition of ad-tech firm Nativo, pointing to diverse revenue streams beyond just app subscriptions.

There are a few stand-out fundamentals for Life360:

• Market capitalisation of $4.91 billion—significantly larger than Droneshield, showing real global ambition and scale.
• A positive earnings per share (EPS) of $0.573, paired with a P/E ratio of 24.59—showing strong underlying profitability for a tech stock, even though it’s had a rough run this year.
• No dividend on offer, but this is common among fast-growing tech companies who’d rather reinvest in expansion.

Year to date, the stock has fallen sharply (down 40%), but investors may see this as an opportunity to buy a global leader well below its earlier highs.

The case for Droneshield

Droneshield is an Australian defence tech business focused on creating artificial intelligence-powered hardware and software to detect, disrupt, and protect against rogue drones. Its product suite serves a serious need for governments, airports, and critical infrastructure, keeping unwelcome drones out of sensitive airspace. The company has growing reach in Australia, the US, and the UK, and sits at the intersection of cybersecurity, national security, and emerging technology.

Here’s what jumps out in Droneshield’s fundamentals:

• Market cap of $1.60 billion—quite a bit smaller than Life360, but still marking it as a noteworthy mid-cap disruptor on the ASX.
• EPS is negative at -$0.033, and the P/E ratio is an eye-watering 433.75. This high multiple reflects the market’s expectations for future earnings growth, but also signals just how little earnings Droneshield is generating today. (Note: Droneshield’s reported P/E ratio may be based on a different earnings measure than the EPS figure shown, which is why they may appear inconsistent.)
• Like Life360, there’s no dividend on offer as the company remains laser-focused on reinvestment and scaling up.

Year to date, the share price has also had a rough run (down 41.4%), despite megatrends like defence spending and security concerns staying front of mind globally.

Valuation comparison

When it comes to key valuation and size metrics, here’s how both tech businesses compare:

	Life360	Droneshield
Market Cap	$4.91 billion	$1.60 billion
P/E Ratio	24.59	433.75
Earnings per Share (EPS)	0.573	-0.033
Dividend Yield	0.00%	0.00%
YTD Return	-39.99%	-41.40%

Both companies don’t pay dividends, so income investors may look elsewhere. The big contrast is in valuation: Life360’s P/E ratio is much closer to what many would expect for a profitable tech stock, while Droneshield’s enormous P/E suggests the market is pricing in very strong future growth, despite its currently negative EPS.

Recent share price momentum

Comparing recent share price performance up to 6 October 2026:

• Life360 closed at $20.12, slipping 0.98% on the day. Over the recent fortnight, it’s mostly traded between $18.90 and $20.50, showing a mix of swings but little clear upward momentum. Its YTD return sits at -39.99%.
• Droneshield finished at $1.73, down 3.88% for the session. Over the same time, it’s moved between $1.58 and $1.83, likewise failing to show a bounce-back. Its YTD performance is -41.4%.

Both stocks are down around 40% over the year to date and have struggled to generate positive momentum in recent weeks.

Which is the better buy?

For me, Life360 Inc stands out over Droneshield at this point. Here’s why: Life360 boasts solid positive earnings, a reasonable P/E ratio for a scale tech stock, and a diverse, global user base with proven monetisation through both subscriptions and advertising. While its share price has sunk this year, I think the fundamentals and business model are robust—and current price weakness could offer a compelling entry point for patient investors.

Droneshield is an exciting, high-potential business in a vital industry. Yet, with its high P/E and negative EPS, I see it as much more speculative at present: the market’s pricing in a lot of future hope, rather than current profits.

Neither pays a dividend, and both have copped it price-wise in 2026. But if I had to pick between the two right now, my pick would be Life360 for its stronger profitability, larger market presence, and more reasonable valuation. For those who crave a pure growth punt on future tech, Droneshield could appeal, but for me, Life360 offers a better mix of scale and earnings power today.

The post Life360 vs Droneshield: Which ASX tech stock is a better buy? appeared first on The Motley Fool Australia.

More reading

• These 3 ASX shares have the ingredients of long-term compounders
• Droneshield vs NextDC: Which ASX tech share is the better buy?
• 3 ASX 200 shares I’d buy and hold for the next decade
• 2 ASX shares highly recommended to buy: Experts
• Should I invest $1,000 into DroneShield shares?

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield and Life360. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial draft. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

A 10% share price gain over 12 months is never guaranteed.

But when I look across the S&P/ASX 200 Index (ASX: XJO), there are a few shares where I think earnings growth, improving business performance, or a more attractive starting valuation could support that sort of return.

These are three ASX 200 shares I would be watching.

Breville Group Ltd (ASX: BRG)

Breville is the first one on my list. The appliance maker has built a strong global business around premium kitchen products, particularly coffee machines, and I think there is still plenty of room to expand internationally.

What I like is that Breville does not need to rely on one market for growth. It has established positions in Australia, North America, and Europe, while newer markets can provide another leg over time.

There is also a product development element to the story. Breville has consistently invested in new appliances and higher-value products, which can help support revenue growth without depending entirely on geographic expansion.

If the company continues to grow earnings and make progress across its international markets, I think a gain of more than 10% over the next year is achievable.

Treasury Wine Estates Ltd (ASX: TWE)

Treasury Wine Estates is a very different proposition. The wine company owns a collection of premium brands, led by Penfolds, which gives it exposure to consumers willing to pay considerably more for higher-end products.

For me, the opportunity is about getting more value from those brands across international markets. A stronger contribution from Asia could be particularly important, while the company also has room to keep growing its premium wine portfolio in markets such as the United States.

Of course, wine is not an easy category. Consumer demand can fluctuate, inventory needs to be managed carefully, and international markets can change quickly.

But that also means sentiment can move sharply when trading improves. If Treasury Wine Estates can show that earnings momentum is strengthening, I think the market could become noticeably more positive on the ASX 200 share over the next 12 months.

ResMed Inc (ASX: RMD)

ResMed is my third pick. The sleep treatment company operates in a large global market, with millions of people affected by sleep apnoea and many more still undiagnosed or untreated.

That gives ResMed a long runway even before considering further product innovation and improvements in diagnosis.

I also like the earnings outlook. Consensus forecasts point to earnings per share (EPS) increasing from $1.54 in FY26 to $1.69 in FY27, $1.85 in FY28, and $2.02 in FY29.

That works out to annualised earnings growth of roughly 9.5% across the three years. For a global healthcare leader, I think that is a healthy pace.

If ResMed delivers close to those expectations and sentiment towards the shares improves, I can easily see scope for the share price to rise more than 10% over the next year.

Foolish takeaway

I would not buy any shares purely because I think they can rise 10% in 12 months.

But Breville, Treasury Wine Estates, and ResMed all have business-specific reasons that I think could support a stronger share price from here.

For me, that makes all three worth considering today.

The post 3 ASX 200 shares I think could rise more than 10% in a year appeared first on The Motley Fool Australia.

More reading

• Is this cheap ASX dividend share one of the best income buys?
• 4 ASX shares tipped by brokers to return 18% to 96%
• ResMed vs Fisher & Paykel Healthcare: Which is better value?
• These are the 10 most shorted ASX shares
• How to build a $52,000 passive income with ASX shares

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed and Treasury Wine Estates. The Motley Fool Australia has positions in and has recommended ResMed and Treasury Wine Estates. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

A couple of years ago, the idea of WiseTech Global Ltd (ASX: WTC) shares falling to $50 would have seemed almost unthinkable.

The logistics software company was growing rapidly, investors were willing to pay extraordinary valuations for that growth, and it seemed the share price could only keep climbing.

Things look quite different today.

With WiseTech shares trading around $32.09, $50 is now a target that would require a substantial recovery.

But could the company get there in 2027 or 2028?

What happened to WiseTech shares?

WiseTech has had a difficult couple of years, and there is more to the share price collapse than a simple change in market sentiment.

Governance controversies surrounding founder Richard White have damaged investor confidence, artificial intelligence (AI) disruption concerns have weighed on sentiment, while the acquisition of e2open has brought integration costs, additional debt, and questions about execution.

The business has also been changing rapidly.

WiseTech is embedding AI into its products and operations, restructuring its workforce, and moving CargoWise customers towards a new commercial model.

That shift away from traditional seat-based fees towards transaction-driven revenue could eventually prove valuable. But investors understandably want to see how it translates into sustainable earnings growth.

I think all these developments have contributed to a major reassessment of what the market is prepared to pay for WiseTech shares.

The days of investors automatically awarding the company an eye-watering earnings multiple appear to be over.

Why I still like the business

Despite everything that has happened, I think WiseTech still has an excellent underlying business.

Its CargoWise platform is deeply embedded in the operations of major logistics companies, helping them manage shipments, customs requirements, documentation, and other complex processes.

Replacing that technology would be a significant undertaking for many customers, particularly those operating across multiple countries.

That gives WiseTech a strong position from which to keep growing.

The acquisition of e2open also broadens its reach beyond freight forwarders into other parts of global supply chains.

If management can successfully integrate the two businesses, I think there is considerable scope to improve efficiency and offer customers more services.

AI could provide another growth opportunity. WiseTech is developing tools to automate more of the work its customers perform, potentially increasing the value of CargoWise as logistics operations become more digital.

The challenge is demonstrating that these changes can produce the sustained earnings growth investors once took for granted.

Could WiseTech shares reach $50?

Consensus forecasts point to earnings per share (EPS) of $1.44 in FY27, increasing to $1.91 in FY28 and $2.31 in FY29.

That represents expected earnings growth of more than 60% between FY27 and FY29.

At the current share price of $32.09, WiseTech shares are trading on a P/E ratio of around 22 times FY27 earnings, falling to approximately 17 times FY28 earnings and just 14 times FY29 earnings.

I think those multiples will prove to be cheap if the company can deliver anything close to the expected growth.

So what would $50 require?

Based on FY27 forecasts, it would put WiseTech on a P/E ratio of almost 35 times. That would be a fairly demanding valuation given everything investors have experienced recently.

But looking further ahead changes the picture. At $50, WiseTech would trade on approximately 26 times FY28 earnings and less than 22 times FY29 earnings.

I think those are realistic multiples for a global software company capable of growing earnings at the rate analysts currently expect.

That makes $50 a plausible target in 2027 or 2028, particularly if investors become more confident that earnings growth can continue into the 2030s.

Foolish takeaway

I think WiseTech shares could return to $50 over the next couple of years.

The company has plenty of work ahead to rebuild confidence. But if management can deliver on growth expectations and demonstrate there is plenty more to come beyond FY29, I think $50 is a realistic target without needing the market to return to its old valuation extremes.

The post Could WiseTech shares be worth $50 again? appeared first on The Motley Fool Australia.

More reading

• These 3 ASX shares have the ingredients of long-term compounders
• AGL, Cochlear, WiseTech shares: Buy, hold, sell
• Tech shares shine while ASX 200 plunges to 4-month low
• Here are the top 10 ASX 200 shares today
• 5 ASX 200 shares brokers tip to rocket 25% to 77%

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Fortescue Ltd (ASX: FMG) has posted a 6% drop in iron ore shipments for the September 2026 quarter, with net debt rising after the payment of a final dividend.

What did Fortescue report?

• Total iron ore shipments of 46.8 million tonnes (Mt), down 6% on the prior corresponding period
• Hematite realised price averaged US$80 per dry metric tonne (82% of Platts 61% CFR Index)
• Cash of US$3.2 billion and net debt climbed to US$2.8 billion at 30 September 2026
• Final FY26 dividend payment of US$1.0 billion made during the quarter
• Quarterly capital expenditure was US$0.9 billion

What else do investors need to know?

Iron ore shipments were affected by scheduled maintenance, including port shutdowns, although supply chain stock levels remained healthy at the end of the quarter. Operating cash flow was impacted by increased working capital and rising product inventory.

Iron ore sales volumes (42.9Mt) were lower than total shipments, reflecting ongoing contract negotiations with China Mineral Resources Group (CMRG). Importantly, Fortescue has kept its full-year 2027 guidance for shipments, C1 unit cost, and capital expenditure unchanged, though these remain subject to reaching an agreement with CMRG.

What’s next for Fortescue?

Investors should keep an eye on negotiations with CMRG, as these remain key to Fortescue’s sales volumes and overall guidance for FY27. With inventories up and guidance unchanged, management appears confident of navigating the current challenges while maintaining healthy supply levels.

Looking ahead, the company’s focus will likely remain on operational efficiency and the resolution of customer negotiations. The full September quarter Production Report, due 22 October, may provide further detail.

Fortescue share price snapshot

Over the past 12 months, Fortescue shares have declined 17%, trailing the S&P/ASX 200 Index (ASX: XJO), which has declined 2% over the same period.

View Original Announcement

The post Fortescue posts September 2026 quarterly earnings update appeared first on The Motley Fool Australia.

More reading

• NextDC, Generation Development, Fortescue shares hit 52-week low. Can they rebound?
• Fortescue vs PLS Group: Which ASX mining share is the better buy?
• Fortescue vs National Australia Bank: Which ASX blue chip is the better buy this month?
• Is the Fortescue share price a cheap buy?
• Regis Resources vs Fortescue: Which ASX miner is the better buy?

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Ramelius Resources Ltd (ASX: RMS) share price is in focus today after the miner reported September quarter gold production of 48,839 ounces and underlying free cash flow of A$60.2 million.

What did Ramelius Resources report?

• Gold production: 48,839 ounces
• FY27 production guidance: 205,000 – 225,000 ounces
• Underlying free cash flow: A$60.2 million
• Cash and gold balance: A$768 million (up from A$649.6 million at 30 June 2026)
• Ore stockpile: 27,680 tonnes at 4.78 g/t (4,254 contained ounces)
• Ongoing A$250 million share buyback, with A$18 million completed in the quarter

What else do investors need to know?

Production was slightly impacted by wet weather in September, delaying haulage from the high-grade Penny mine, but haulage has now recommenced. The company remains confident in achieving its full-year gold production guidance.

Ramelius continues to advance its growth projects, including the Mt Magnet mill expansion, with installation underway on a new crusher and gravity tower. The Rebecca-Roe project received a key environmental Works Approval during the quarter, moving it closer to full approval.

The sale of Edna May was completed for A$300 million, boosting the company’s financial position and enabling continued investment in expansion and exploration.

What did Ramelius Resources management say?

Managing Director Mark Zeptner said:

We continue to build on the strong momentum from last financial year particularly with Dalgaranga ramping up tonnages, commissioning the new paste plant and continuing to out-perform on grade and recovery expectations. We are excited to see construction activities taking place on the Mt Magnet mill expansion and are bringing forward some capital expenditure at Rebecca-Roe as we near finalisation of all required approvals.

What’s next for Ramelius Resources?

Ramelius is set to progress its 4-year growth strategy targeting more than 600,000 ounces of gold production by FY30. The recent resource upgrades and project approvals back its plan for sustained output through to the late 2030s.

With a strong balance sheet, ongoing buybacks, and an active exploration program, Ramelius aims to displace lower-grade material and maximise output at key sites, focusing on discovery and development opportunities.

Ramelius Resources share price snapshot

Over the past 12 months, Ramelius Resources shares have declined 8%, trailing the S&P/ASX 200 Index (ASX: XJO), which has declined 2% over the same period.

View Original Announcement

The post Ramelius Resources September quarter earnings: Gold production update and outlook appeared first on The Motley Fool Australia.

More reading

• 6 ASX shares set to soar 39% to 135%
• 3 ASX shares given buy ratings this week offering 20% to 40% upside
• 5 ASX 200 shares upgraded by experts this week
• Here are the top 10 ASX 200 shares today
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

ASX passive income shares are some of my favourite stocks to buy because they pay real cash flow into our bank accounts. Some of them have incredibly high dividend yields.

Uncertainty in the wider economy and higher interest rates have pushed share prices lower and, in turn, sent dividend yields higher.

With that in mind, there are a few high-yield names that come to mind, and the two below are among the most attractive.

Charter Hall Long WALE REIT (ASX: CLW)

The first business I want to highlight is this real estate investment trust (REIT), which has a highly diversified portfolio spanning sectors such as service stations, hotels, office buildings, Bunnings properties, and distribution centres.

Higher interest rates are particularly a headwind for REITs because they increase the cost of debt (which REITs tend to have), and it’s a headwind for property valuations. But I don’t expect interest rates to stay this high forever, meaning that this is a useful time to invest.

The Charter Hall Long WALE REIT unit price has dropped 24% in the past year (at the time of writing), but I don’t think the underlying business is worth 24% less than it was before.

It has several positive factors, including a weighted average lease expiry (WALE) of around 9 years, which provides long-term rental income security. That rent is regularly growing thanks to a mixture of fixed annual increases and inflation-linked increases.

The business plans to maintain its annual distribution at 25.5 cents per unit in FY27, which translates into a forward distribution yield of 8.4%.

WAM Microcap Ltd (ASX: WMI)

This listed investment company (LIC) is the other ASX passive income share idea that I want to highlight with a huge dividend yield.

LICs are a great structure because they allow investors to gain exposure to a portfolio of shares and can turn some of the generated investment profits into a steady (or growing) dividend.

WAM Microcap looks to invest in the smallest businesses on the ASX, ones with a market capitalisation under $300 million at the time of investment.

The LIC grew its regular annual dividend each year between FY18 and FY23, maintained it in FY24, and grew it slightly in FY25 and FY26.

Its FY26 annual dividend per share of 10.7 cents translates into a huge grossed-up dividend yield of 11.75%, including franking credits, at the time of writing. While the business only grew its annual dividend by 1% in FY26, any increase is useful when you’re talking about a double-digit yield.

WAM Microcap needs to keep delivering investment returns to grow its dividend, but its current profit reserve covers more than four years of payments at the current level.

$600 of passive income per month

Between the two stocks above, the average dividend yield is around 10%, including franking credits.

To reach $600 per month in income, we should set an annual goal, since they don’t pay monthly. The target is $7,200 per year. For that level of income, an investor would need around $72,000 invested in the two names above.

But I’d suggest spreading investment dollars across additional ASX share ideas that can generate returns, rather than putting too much in just two names.

The post 2 ASX passive income share ideas I’d use to generate $600 a month in 2027 appeared first on The Motley Fool Australia.

More reading

• How much do I need to retire on $85,000 a year at 50?
• 6 ASX REITs just hit 52-week lows. Do any brokers say buy?
• How much do I need to retire on $110,000 a year at 65?
• Where I’d invest in ASX shares after the recent RBA rate rise
• 2 very cheap ASX shares near 52-week lows I’d buy today

Motley Fool contributor Tristan Harrison has positions in Wam Microcap. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Broker UBS has just significantly upgraded its share price target for Telix Pharmaceuticals Ltd (ASX: TLX) after the company announced some positive news this week.

Good news out of the US

Telix said earlier this week that it had been granted fast-track designation by the US Food and Drug Administration for its BiPASS program, which is evaluating a new compound to be used in prostate cancer detection.

BiPASS (Biopsy of the Prostate Avoidance Stratification Study) is evaluating the use of gallium-68 PSMA-PET imaging in combination with MRI for the detection of prostate cancer prior to taking a biopsy.

The company said this week that there was a large clinical need to develop a method to detect the cancer without a biopsy.

Telix said:

Fast Track is a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need, potentially accelerating patient access if approved. More than three million prostate biopsies are performed globally each year, yet up to 75% produce a negative result. Biopsy can be stressful and painful for patients and may provide no meaningful diagnostic benefit, highlighting the importance of improved diagnostic tools earlier in the patient journey.

Broker says the market could be large

UBS said if the BiPASS study is successful, it could expand the total addressable market for Telix’s PSMA compounds by almost 100%.

They said:

Success would establish Telix as first to market in a large new diagnostic indication, a potentially transformative opportunity. We believe the market underappreciates both the commercial upside and probability of success of the BiPASS study.

UBS said its confidence was supported by data from two previous studies and feedback highlighting that there was a strong unmet need and a high likelihood of adoption.

They added:

We believe the FDA New Drug Application pathway and Transitional Pass Through payments could accelerate commercialisation and support higher peak sales than current expectations. We forecast a 10% FY26-FY35 CAGR for Telix’s PSMA-PET franchise versus 6% implied by consensus. If BiPASS is successful, we expect meaningful uptake from FY29, with FDA approval partially de-risked and the recent Fast Track designation encouraging.

UBS said Telix was a rare biotechnology company in that it had a broad, advanced pipeline funded by its established precision medicine business.

They said the company also had a deep therapeutic pipeline supported by the recently announced acquisition of ITM.

UBS raised its price target on Telix shares from $22 to $26, compared with $16.19 at the time of writing.

This would constitute a 60.6% increase if achieved. Telix is valued at $5.24 billion.

The post UBS thinks Telix Pharmaceuticals shares will go how high? appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• Telix Pharmaceuticals wins FDA Fast Track for BiPASS prostate cancer imaging
• Buy, hold, sell: Telix Pharmaceuticals, Qualitas, Greatland Resources shares
• These are the 10 most shorted ASX shares
• 2 ASX shares UBS says could increase 13% to 37%

Motley Fool contributor Cameron England has positions in Telix Pharmaceuticals. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The West African Resources Ltd (ASX: WAF) share price is on the radar after the company posted record group gold production of 127,950 ounces for the September quarter, helping YTD output to reach 360,857 ounces and supporting full-year guidance.

What did West African Resources report?

• Q3 Group gold production: 127,950 ounces
• Q3 Group gold sales: 135,245 ounces at an average realised price of US$4,240/oz
• Year-to-date gold production: 360,857 ounces
• Year-to-date gold sales: 350,127 ounces at US$4,550/oz
• Mining commenced at the M5 South underground deposit
• On track to achieve 2026 annual production guidance of 430,000–490,000 ounces

What else do investors need to know?

Mining at the M5 North open pit at Sanbrado improved, showing an 8% increase in mined ounces over the previous quarter, although slightly lower ore tonnes were processed. At Kiaka, open pit mining delivered an 11% boost in mined ounces, driven by more ore tonnes despite a slight dip in grade.

The company received government approval to update the Sanbrado life-of-mine plan, allowing for M5 South underground mining to kick off. Although explosives supply at Kiaka remains a bottleneck, improvements were seen with better supplier performance and onboarding of a second supplier.

What did West African Resources management say?

Executive Chairman and CEO Richard Hyde said:

WAF delivered another record quarter in Q3, with Group gold production of 127,950 ounces from our two large low-cost gold production centres of Sanbrado and Kiaka, which maintains our run rate at over 500,000 ounces per annum. YTD production of 360,857 ounces well-positions WAF to achieve our 2026 annual production guidance of 430,000 – 490,000 ounces of gold. I look forward to releasing our full quarterly activities report in the coming weeks.

What’s next for West African Resources?

West African Resources remains confident in achieving its 2026 annual gold production guidance, with strong operational performances at both Sanbrado and Kiaka. Development at M5 South underground is underway, with stoping due to begin in early H2 2027.

The company will continue to address operational challenges, such as explosives access at Kiaka, and expects greater flexibility in its mine plan to support steady production going forward.

West African Resources share price snapshot

Over the past 12 months, West African resources shares have risen 28%, outperforming the S&P/ASX 200 Index (ASX: XJO), which has declined 2% over the same period.

View Original Announcement

The post West African Resources delivers record Q3 gold output, on track for 2026 targets appeared first on The Motley Fool Australia.

More reading

• Downgrade alert! 5 ASX 200 shares downgraded by experts this week
• 5 things to watch on the ASX 200 on Thursday
• Here are the top 10 ASX 200 shares today
• West African Resources’ new dividend yield might surprise
• West African Resources delivers profit surge and special dividend in H1 2026

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

NextDC Ltd (ASX: NXT), Generation Development Group Ltd (ASX: GDG), and Fortescue Ltd (ASX: FMG) shares closed at fresh 52-week lows on Wednesday afternoon.

Here’s what has happened to the ASX shares, and what brokers expect next.

NextDC shares

NextDC shares dropped around 2% on Wednesday and closed the day at just $10.23 a piece. That’s the lowest close price the data centre operator’s shares have traded at since March 2023.

At one point in the late afternoon, the ASX shares even fell as low as $10.17 each. They’ve now crashed around 20% over the past month, and are down 17% for the year to date.

There hasn’t been any price-sensitive news out of the business to explain the latest sell-off. It’s likely that investors are still digesting the company’s disappointing FY26 results announcement in late August.

A higher interest rate environment and climbing inflation are also likely spooking investors and causing many to rotate towards more defensive assets. 

The good news is that NextDC’s offerings – being physical data centres, including cooling, power, and security – are expected to benefit from stronger demand as data usage increases.

NextDC may have tumbled to a new multi-year low, but if analyst forecasts are anything to go by, it could be an opportune time for investors to buy in the dip.

Market Index data shows all brokers have a strong buy rating on the shares. The average $20.79 target price implies an upside of around 103% at the time of writing.

Generation Development Group shares

Generation Development Group shares closed around 1% lower on Wednesday afternoon, at a two-year low of $2.65 a piece. The diversified financial services company’s shares have now fallen roughly 21% over the past month, and are down a huge 55% so far in 2026.

Like NextDC, there hasn’t been any price-sensitive news out of the company to explain the latest decline. Generation Development Group’s latest market update was its FY26 financial results in late August. 

The company posted a record 37% year-on-year increase in funds under management, and a 21% rise in underlying NPAT. Group revenue also climbed 23%. 

The sell-off is most likely the result of a broad-based rotation away from financial shares over the past month, amid a higher interest rate environment and sky-high bond yields.

But Generation Development Group thinks it is well-placed to benefit from strong structural tailwinds across superannuation, retirement, and managed account markets in FY27. 

Again, the experts are optimistic that the ASX shares can rebound from the latest slump. Market Index data shows that all brokers have a strong buy rating on the shares. The $5.62 average target price implies an upside of around 112% at the time of writing.

Fortescue shares

Fortescue shares also tumbled around 2.5% on Wednesday, closing at $16.01 a piece. That’s the lowest trading price the ASX iron ore stock has seen since June 2025. The shares have also fallen 10% over the past month and are down 28% year to date.

The shares have mostly been hit by headwinds from falling iron ore prices. The company generates substantial cash flow from its large iron ore operations, so rising iron ore prices are a tailwind and falling prices are a headwind for the miner. 

At the time of writing, iron ore is trading at around US$91 per tonne, according to Trading Economics data. That’s the lowest price the metal has experienced since November 2022.

It looks like the experts are concerned that there is room for the shares to stage a turnaround over the next 12 months. Unless there is a sharp turnaround in the price of iron ore, Fortescue shares may continue to be under pressure.

Market Index data shows that the majority of brokers have a hold rating on the shares. But after the latest slump, the $17.88 average target price still implies a potential 12% upside ahead.

The post NextDC, Generation Development, Fortescue shares hit 52-week low. Can they rebound? appeared first on The Motley Fool Australia.

More reading

• Fortescue vs PLS Group: Which ASX mining share is the better buy?
• Droneshield vs NextDC: Which ASX tech share is the better buy?
• 4 ASX shares tipped by brokers to return 18% to 96%
• 3 ASX shares tipped to fly 109% to 322% higher
• Buy, hold, sell: New Hope, Cleanaway Waste Management, NextDC shares

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Generation Development Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.